Clinical Trials Logo

Clinical Trial Summary

Since the beginning of COVID-19 pandemic, a safe and effective vaccine against infection and development of acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is needed control of the wide spread of COVID-19 and reduce death rates throughout the world. Many clinical trials investigated the immunogenicity of different proposed vaccine including the first distributed vaccine; the ChAdOx1 nCoV-19 vaccine and there is a need to analyze the results of published clinical trials.

Clinical Trial Description


Study Design

NCT number NCT05060861
Study type Observational
Source Assiut University
Status Active, not recruiting
Start date June 1, 2021
Completion date October 30, 2021